Jiuzhitang Co., Ltd. (SHE:000989)

China flag China · Delayed Price · Currency is CNY
8.98
0.00 (0.00%)
At close: Feb 24, 2026
Market Cap7.60B +16.9%
Revenue (ttm)1.94B -27.1%
Net Income127.43M -48.8%
EPS0.15 -48.5%
Shares Out846.28M
PE Ratio59.67
Forward PEn/a
Dividend0.30 (3.34%)
Ex-Dividend DateMay 8, 2025
Volume8,747,666
Average Volume10,926,087
Open9.02
Previous Closen/a
Day's Range8.95 - 9.07
52-Week Range7.22 - 13.30
Beta0.41
RSI49.43
Earnings DateMar 27, 2026

About Jiuzhitang

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment: Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong capsules for gynecological treatment; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription dru... [Read more]

Sector Healthcare
Founded 1999
Employees 3,689
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000989
Full Company Profile

Financial Performance

In 2024, Jiuzhitang's revenue was 2.37 billion, a decrease of -19.91% compared to the previous year's 2.96 billion. Earnings were 216.20 million, a decrease of -27.31%.

Financial Statements